Patient Direct Segment Growth
The Patient Direct segment saw a top-line growth in the mid-single digits, with operating income growing by 31%, translating to a $14 million increase and a 173 basis point expansion.
Successful Sleep Journey Investment
Investments in the sleep journey led to a meaningful increase in sleep starts and high single-digit revenue growth in sleep supplies for the first quarter.
Expansion in Commercial Resources
Expansion in commercial resources resulted in double-digit growth in categories like wound supplies, ostomy, and urology.
New Distribution Centers
Opened new state-of-the-art distribution centers in Morgantown, West Virginia, and Sioux Falls, South Dakota.
Record Collection Rates
Record collection rates were achieved in the Byram division, with plans to replicate this in the Apria division by year-end.
Revenue Growth
Overall revenue for the quarter was $2.6 billion, up 2.3% on a same-day basis compared to the prior year.
Adjusted Operating Income Increase
Adjusted operating income increased by about 7% versus Q1 2024.